Morgan Stanley Downgrades Ironwood Pharmaceuticals (IRWD) to Equalweight

April 24, 2013 7:39 AM EDT
Get Alerts IRWD Hot Sheet
Price: $15.16 +0.80%

Rating Summary:
    10 Buy, 11 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 22 | New: 54
Trade IRWD Now!
Join SI Premium – FREE
Morgan Stanley downgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Ironwood Pharmaceuticals click here. For more ratings news on Ironwood Pharmaceuticals click here.

Shares of Ironwood Pharmaceuticals closed at $16.77 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Downgrades, Hot Downgrades

Related Entities

Morgan Stanley

Add Your Comment